Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-049653

Director sold 5,000 shares at an average $180.42 ($902,102)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-02 Sale : show line 1 in the form −1,100 $178.48 $196,323 390,516 D
2021-08-02 Sale : show line 2 in the form −1,140 $179.53 $204,669 389,376 D
2021-08-02 Sale : show line 3 in the form −960 $180.33 $173,115 388,416 D
2021-08-02 Sale : show line 4 in the form −1,100 $181.47 $199,620 387,316 D
2021-08-02 Sale : show line 5 in the form −400 $182.74 $73,096 386,916 D
2021-08-02 Sale : show line 6 in the form −200 $183.90 $36,780 386,716 D
2021-08-02 Sale : show line 7 in the form −100 $184.99 $18,499 386,616 D
Open-market sales · 5,000 sh · avg $180.42 · $902,102
Loading xslF345X03/doc4.xml…